BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14638371)

  • 21. Critical evaluation of diagnosing bacterial overgrowth in the proximal small intestine.
    Kerckhoffs AP; Visser MR; Samsom M; van der Rest ME; de Vogel J; Harmsen W; Akkermans LM
    J Clin Gastroenterol; 2008; 42(10):1095-102. PubMed ID: 18936644
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Re: Pimentel et al.--Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.
    Mishkin D; Mishkin S
    Am J Gastroenterol; 2001 Aug; 96(8):2505-6. PubMed ID: 11513203
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.
    Choung RS; Ruff KC; Malhotra A; Herrick L; Locke GR; Harmsen WS; Zinsmeister AR; Talley NJ; Saito YA
    Aliment Pharmacol Ther; 2011 May; 33(9):1059-67. PubMed ID: 21395630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Enterosan--perspective medications for patients with postinfection irritable bowel syndrome].
    Parfenov AI; Ruchkina IN
    Eksp Klin Gastroenterol; 2011; (3):102-4. PubMed ID: 21695957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial overgrowth as a cause of irritable bowel syndrome.
    Riordan SM; Kim R
    Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Culture-proven small intestinal bacterial overgrowth as a cause of irritable bowel syndrome: response to lactulose but not broadspectrum antibiotics.
    Kurtovic J; Segal I; Riordan SM
    J Gastroenterol; 2005 Jul; 40(7):767-8. PubMed ID: 16082596
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacterial concepts in irritable bowel syndrome.
    Lin HC; Pimentel M
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():S3-9. PubMed ID: 17713456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small intestinal bacterial overgrowth as an uncommon cause of false positive lactose hydrogen breath test among patients with diarrhea-predominant irritable bowel syndrome in Asia.
    Wang Y; Xiong L; Gong X; Li W; Zhang X; Chen M
    J Gastroenterol Hepatol; 2015 Jun; 30(6):995-1000. PubMed ID: 25470082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of small bowel bacterial overgrowth.
    Schiller LR
    Curr Gastroenterol Rep; 2007 Oct; 9(5):373-7. PubMed ID: 17991337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the rice breath hydrogen test for small intestinal bacterial overgrowth.
    Riordan SM; McIver CJ; Duncombe VM; Thomas MC; Bolin TD
    Am J Gastroenterol; 2000 Oct; 95(10):2858-64. PubMed ID: 11051360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small intestinal bacterial overgrowth produces symptoms in irritable bowel syndrome which are improved by rifaximin. A pilot study.
    Moraru IG; Portincasa P; Moraru AG; Diculescu M; Dumitraşcu DL
    Rom J Intern Med; 2013; 51(3-4):143-7. PubMed ID: 24620626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysis.
    Chen B; Kim JJ; Zhang Y; Du L; Dai N
    J Gastroenterol; 2018 Jul; 53(7):807-818. PubMed ID: 29761234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.
    Gasbarrini A; Scarpellini E; Gabrielli M; Tortora A; Purchiaroni F; Ojetti V
    Aliment Pharmacol Ther; 2011 Jun; 33(12):1378-9; author reply 1379-80. PubMed ID: 21569063
    [No Abstract]   [Full Text] [Related]  

  • 34. Hydrogen sulphide in exhaled breath: a potential biomarker for small intestinal bacterial overgrowth in IBS.
    Banik GD; De A; Som S; Jana S; Daschakraborty SB; Chaudhuri S; Pradhan M
    J Breath Res; 2016 May; 10(2):026010. PubMed ID: 27163246
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of irritable bowel syndrome after an episode of bacterial gastroenteritis in general practice: influence of comorbidities.
    Ruigómez A; García Rodríguez LA; Panés J
    Clin Gastroenterol Hepatol; 2007 Apr; 5(4):465-9. PubMed ID: 17445753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High dosage rifaximin for the treatment of small intestinal bacterial overgrowth.
    Scarpellini E; Gabrielli M; Lauritano CE; Lupascu A; Merra G; Cammarota G; Cazzato IA; Gasbarrini G; Gasbarrini A
    Aliment Pharmacol Ther; 2007 Apr; 25(7):781-6. PubMed ID: 17373916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Small intestinal bacterial overgrowth in patients with functional gastrointestinal diseases].
    Madrid AM; Defilippi C C; Defilippi G C; Slimming A J; Quera P R
    Rev Med Chil; 2007 Oct; 135(10):1245-52. PubMed ID: 18180830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?
    Gupta A; Chey WD
    Am J Gastroenterol; 2016 Mar; 111(3):305-6. PubMed ID: 26925880
    [No Abstract]   [Full Text] [Related]  

  • 39. Breath hydrogen excretion in patients with alcoholic liver disease--evidence of small intestinal bacterial overgrowth.
    Bode C; Kolepke R; Schäfer K; Bode JC
    Z Gastroenterol; 1993 Jan; 31(1):3-7. PubMed ID: 8447153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of small intestinal bacterial overgrowth: the challenges persist!
    Abu-Shanab A; Quigley EM
    Expert Rev Gastroenterol Hepatol; 2009 Feb; 3(1):77-87. PubMed ID: 19210115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.